DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal (Risperidone) - Drug Ineffective - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Drug Ineffective (62)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal (Risperidone) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 62   Next >>

Possible Risperdal side effects in 21 year old male

Reported by a individual with unspecified qualification from United States on 2012-08-23

Patient: 21 year old male, weighing 63.5 kg (139.7 pounds)

Reactions: Anxiety, Irritability, Off Label Use, Drug Ineffective, Drug Intolerance, Abnormal Behaviour

Drug(s) suspected as cause:
Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-01
    End date: 2012-01-01

Risperdal

Seroquel
    Administration route: Oral
    Start date: 2012-04-01
    End date: 2012-06-20

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2012-03-01
    End date: 2012-01-01

Seroquel
    Administration route: Oral
    Start date: 2012-04-01
    End date: 2012-06-20

Other drugs received by patient: Miralax



Possible Risperdal side effects in

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient:

Reactions: Weight Increased, Drug Ineffective, DRY Throat

Drug(s) suspected as cause:
Ziprasidone HCL
    Dosage: unk

Risperdal
    Dosage: unk



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01



Possible Risperdal side effects in 21 year old male

Reported by a individual with unspecified qualification from United States on 2012-07-31

Patient: 21 year old male

Reactions: Drug Ineffective, Drug Intolerance

Drug(s) suspected as cause:
Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral

Risperdal



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Risperdal side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-22

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Pneumonia, Drug Ineffective, Diabetes Mellitus, Paranoia, Urinary Tract Infection, Coma, Schizophrenia, Somnolence

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2006-01-01

Zoloft
    Administration route: Oral
    Start date: 2012-01-01

Risperidone
    Indication: Schizophrenia, Paranoid Type

Zoloft
    Administration route: Oral
    Indication: Depression
    Start date: 2007-01-01

Risperdal
    Administration route: Oral
    Indication: Paranoia

Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal
    Administration route: Oral
    Start date: 2006-01-01

Other drugs received by patient: Coumadin; AN Unknown Medication



Possible Risperdal side effects in 81 year old male

Reported by a physician from Germany on 2012-06-22

Patient: 81 year old male

Reactions: Confusional State, Drug Ineffective, Restlessness, Sudden Death, General Physical Health Deterioration, Screaming, Blood Pressure Decreased, Cardiomegaly

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal
    Administration route: Oral
    Start date: 2012-05-09
    End date: 2012-05-11

Dipiperon
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-09
    End date: 2012-05-11

Other drugs received by patient: Pantoprazole; Methizol; Pravastatin; Prochlorperazine; Axura; AN Unknown Medication; Calcium; Mesalazin; Embolex; Torsemide; Prednisolone



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-29

Patient: male, weighing 81.7 kg (179.6 pounds)

Reactions: Anxiety, Incorrect Route of Drug Administration, Weight Increased, Mental Impairment, Drug Ineffective, Hallucination, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Schizophrenia, Paranoid Type
    Start date: 2012-02-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2012-02-01
    End date: 2012-03-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2012-01-01
    End date: 2012-01-01

Risperdal
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-02-01

Risperdal
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-01-01

Risperdal
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-01-01



Possible Risperdal side effects in 21 year old male

Reported by a physician from United States on 2012-05-23

Patient: 21 year old male

Reactions: Drug Ineffective, Drug Intolerance

Drug(s) suspected as cause:
Seroquel
    Administration route: Oral

Seroquel
    Administration route: Oral

Risperdal



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-21

Patient: male, weighing 49.9 kg (109.8 pounds)

Reactions: Personality Change, Increased Appetite, Headache, Off Label Use, Abnormal Dreams, TIC, Bipolar I Disorder, Emotional Disorder, Eye Movement Disorder, Mood Swings, Cough, Crying, Psychomotor Hyperactivity, Restlessness, Rhinitis, Aggression, Apathy, Ear Pain, Drug Ineffective, Quality of Life Decreased, Somnolence, Constipation, Abdominal Pain Upper, Poor Quality Sleep, Weight Increased, Myalgia, Fatigue, Screaming, Anger, Sinusitis, Vomiting, Nausea, Rash, Anxiety, Arthralgia

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2005-01-01

Risperdal
    Dosage: 50 mg 1/2 in the am and 1/2 in pm
    Administration route: Oral

Risperdal
    Dosage: 50 mg 1/2 in the am and 1/2 in pm
    Administration route: Oral
    Indication: Bruxism
    Start date: 2006-01-01
    End date: 2011-01-01

Risperdal
    Dosage: 50 mg 1/2 in the am and 1/2 in pm
    Administration route: Oral
    Indication: Asperger's Disorder
    Start date: 2006-01-01
    End date: 2011-01-01

Risperdal
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2005-01-01

Risperdal
    Dosage: 50 mg 1/2 in the am and 1/2 in pm
    Administration route: Oral

Other drugs received by patient: Effexor; Asthma Inhaler



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02



Possible Risperdal side effects in female

Reported by a physician from Norway on 2012-05-08

Patient: female

Reactions: Restlessness, Drug Ineffective, Parkinsonism, Migraine With Aura, Blood Prolactin Increased, Visual Impairment, Blood Cholesterol Increased, Tardive Dyskinesia, Tension, Latent Autoimmune Diabetes in Adults

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisordinol
    Indication: Schizophrenia, Paranoid Type
    Start date: 1994-01-01

Trilafon
    Dosage: 108 mg/ml

Trilafon
    Indication: Schizophrenia, Paranoid Type

Seroquel
    Indication: Schizophrenia, Paranoid Type
    Start date: 2003-07-01

Risperdal
    Indication: Schizophrenia, Paranoid Type

Trilafon
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 1993-01-01
    End date: 1994-01-01

Risperdal Consta
    Indication: Schizophrenia, Paranoid Type
    Start date: 2003-05-30
    End date: 2003-07-21

Risperdal
    Start date: 2003-05-30
    End date: 2003-07-21



Possible Risperdal side effects in female

Reported by a consumer/non-health professional from China on 2012-05-03

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Product Counterfeit, Drug Ineffective, Completed Suicide, Hallucination

Adverse event resulted in: death

Drug(s) suspected as cause:
Risperdal
    Dosage: night and morning
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2010-01-01

Risperdal
    Dosage: twice a day
    Start date: 2010-01-01
    End date: 2010-10-01

Risperdal
    Dosage: 2 times a day, morning and evening each 2.5ml
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-10-01



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-03

Patient: male

Reactions: Weight Increased, Drug Ineffective, Hyperphagia, Abnormal Behaviour

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2001-01-01

Risperdal
    Administration route: Oral

Risperdal
    Dosage: 4 mg+2 mg in pm
    Administration route: Oral
    Indication: Bipolar Disorder

Risperdal
    Administration route: Oral
    Start date: 2001-01-01

Risperdal
    Administration route: Oral
    Indication: Schizoaffective Disorder

Risperdal
    Dosage: 4 mg+2 mg in pm
    Administration route: Oral

Risperdal
    Dosage: 4 mg in am
    Administration route: Oral

Risperdal
    Dosage: 4 mg in am
    Administration route: Oral

Other drugs received by patient: Lithium Carbonate; Lithium Carbonate



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-23

Patient: male

Reactions: Cataract, Drug Ineffective, Adverse Drug Reaction, Squamous Cell Carcinoma of Skin

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997

Chlorpromazine
    Indication: Hallucination

Risperdal
    Start date: 2011-01-01

Risperdal Consta
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997
    Indication: Hallucination

Risperdal Consta

Chlorpromazine
    Indication: Schizophrenia

Risperdal
    Start date: 2011-01-01

Risperdal
    Indication: Schizophrenia
    Start date: 2011-01-01

Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997
    Indication: Autism

Other drugs received by patient: Levothyroxine Sodium; Depakote; Diphenhydramine HCL; Fluvoxamine Maleate; Paxil; Benztropine Mesylate; Benztropine Mesylate; Lorazepam



Possible Risperdal side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: female, weighing 72.1 kg (158.6 pounds)

Reactions: Drug Ineffective, Cerebrovascular Accident, Amnesia, Stress, Malaise, Insomnia, Nervous System Disorder, Mental Disorder

Drug(s) suspected as cause:
Risperdal
    Dosage: unk
    End date: 2011-01-01

Risperdal
    Dosage: 4 mg, daily
    Indication: Psychotic Disorder
    Start date: 1992-01-01

Risperdal
    Dosage: 3 mg, daily

Lexapro
    Dosage: 20 mg, daily
    Indication: Depression

Geodon
    Dosage: 40 mg, daily
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01

Risperdal
    Dosage: 2 mg, daily

Geodon
    Dosage: 80 mg, daily
    Indication: Psychotic Disorder
    Start date: 2011-01-01

Other drugs received by patient: Zocor; Klonopin; Coreg; Wellbutrin; Altace; Klonopin



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Risperdal side effects in 66 year old male

Reported by a physician from Japan on 2012-04-03

Patient: 66 year old male

Reactions: Drug Ineffective, Dyskinesia, Opisthotonus, Torticollis, Fall, Communication Disorder, Feeling Abnormal, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral

Quetiapine
    Indication: Aggression

Levomepromazine
    Indication: Aggression

Risperdal
    Administration route: Oral
    Indication: Aggression

Risperdal
    Administration route: Oral
    Indication: Insomnia

Quetiapine
    Indication: Insomnia

Levomepromazine
    Indication: Insomnia



Possible Risperdal side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-29

Patient: male

Reactions: Weight Increased, Hyperphagia, Drug Ineffective, Abnormal Behaviour

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Dosage: 4 mg+2 mg in pm
    Administration route: Oral
    Indication: Schizoaffective Disorder

Risperdal
    Dosage: 4 mg+2 mg in pm
    Administration route: Oral

Risperdal
    Administration route: Oral
    Start date: 2001-01-01

Risperdal
    Administration route: Oral
    Start date: 2001-01-01

Risperdal
    Administration route: Oral

Risperdal
    Dosage: 4 mg in am
    Administration route: Oral
    Indication: Bipolar Disorder

Risperdal
    Administration route: Oral

Risperdal
    Dosage: 4 mg in am
    Administration route: Oral

Other drugs received by patient: Lithium Carbonate; Lithium Carbonate



Possible Risperdal side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-16

Patient: female

Reactions: Blood Prolactin Increased, Drug Ineffective

Drug(s) suspected as cause:
Risperdal
    Dosage: 1 mg am and 2 mg pm
    Administration route: Oral
    Indication: Psychotic Disorder

Haldol
    Dosage: from 5 mg up to 30 mg daily
    Administration route: Oral
    Indication: Psychotic Disorder



Possible Risperdal side effects in male

Reported by a physician from Germany on 2012-03-02

Patient: male, weighing 75.8 kg (166.8 pounds)

Reactions: Hospitalisation, Drug Ineffective, Drug Level Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeplion
    Start date: 2011-06-21
    End date: 2011-06-28

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-07-11

Xeplion
    Start date: 2011-07-26
    End date: 2011-08-18

Xeplion
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-06-21
    End date: 2011-06-21

Risperdal
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21

Risperdal
    Administration route: Oral
    Start date: 2011-06-22
    End date: 2011-07-07

Other drugs received by patient: Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium; Valproate Sodium



Possible Risperdal side effects in male

Reported by a lawyer from United States on 2012-02-29

Patient: male

Reactions: Drug Ineffective, Diabetic Ketoacidosis, Type 1 Diabetes Mellitus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Indication: Attention Deficit / Hyperactivity Disorder

Risperdal
    Indication: Bipolar Disorder



Possible Risperdal side effects in male

Reported by a physician from United Kingdom on 2012-02-27

Patient: male

Reactions: Drug Ineffective, Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Anti-Depressants
    Indication: Product Used FOR Unknown Indication



Possible Risperdal side effects in 14 year old male

Reported by a physician from Switzerland on 2012-02-27

Patient: 14 year old male

Reactions: Weight Increased, Increased Appetite, Drug Ineffective

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder

Concerta
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder



Possible Risperdal side effects in 14 year old male

Reported by a physician from Switzerland on 2012-02-27

Patient: 14 year old male

Reactions: Weight Increased, Drug Ineffective, Increased Appetite

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder

Concerta
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder



Possible Risperdal side effects in 16 year old female

Reported by a physician from Japan on 2012-02-22

Patient: 16 year old female

Reactions: Dystonia, Drug Ineffective, Systemic Lupus Erythematosus, Akinesia, Unevaluable Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Mania

Risperidone
    Administration route: Oral
    Indication: Hallucination, Auditory

Risperidone
    Administration route: Oral
    Indication: Delusion

Risperdal
    Administration route: Oral
    Indication: Hallucination, Auditory

Risperdal
    Administration route: Oral
    Indication: Delusion

Risperidone
    Administration route: Oral
    Indication: Mania

Other drugs received by patient: Prednisolone; Olanzapine; Valproate Sodium; Quetiapine Fumarate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017